Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 252
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT00041353 | Comparison of Biomarkers Based on Fine-Needle Aspiration in Women at Increased or Normal Risk of Breast Cancer | ||
| NCT02224482 | Trial of an Online Multimedia Program to Boost Coping & Function for Prostate Cancer Survivors (PROGRESS) | ||
| NCT04506554 | A Study of Risk Enabled Therapy After Neoadjuvant Immunochemotherapy for Bladder Cancer | ||
| NCT00322296 | Phase II Trial to Evaluate the Efficacy of Topical Bexarotene Gel in Patients With Parapsoriasis | ||
| NCT00433524 | Computed Tomography in Detecting Movement of the Esophagus in Patients Undergoing Radiation Therapy to the Chest | ||
| NCT04618809 | Improving the Approach to and Management of the Older Patient With Metastatic Gastric Cancer | ||
| NCT03094884 | Pulsed Low Dose Rate Radiation With Concurrent Chemotherapy for Non-Small Cell Lung Cancer and Esophageal Cancer | ||
| NCT02871752 | Reducing the Effects of Active Surveillance Stress, Uncertainty and Rumination Thru Engagement in Mindfulness Education | ||
| NCT06904339 | Communication About Sexual Health in Gynecologic Cancer | ||
| NCT00002509 | High-Dose Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Poor-Prognosis Breast Cancer | ||
| NCT02710734 | Risk Enabled Therapy After Initiating Neoadjuvant Chemotherapy for Bladder Cancer (RETAIN) | ||
| NCT07517666 | Genetic Information for Families After Tumor Testing Study | ||
| NCT07455032 | Neoadjuvant CADI-05 in Combination With Pembrolizumab for Surgically Resectable Locally Advanced Head and Neck Squamous Cell Carcinomas | ||
| NCT00062309 | Comparison of Two Radiation Therapy Regimens in Treating Patients With Stage II or Stage III Prostate Cancer | ||
| NCT04455698 | Engaging and Activating Cancer Survivors in Genetic Services Study | ||
| NCT03302247 | Depletion of Myeloid Derived Suppressor Cells to Enhance Anti PD-1 Therapy | ||
| NCT01937585 | Trial of Print Messages to Support the Role of Partners in Promoting Provider Discussions About Prostate Cancer Screening Among AA Men | ||
| NCT04262219 | Clinician Communication About Sexual Health | ||
| NCT02272244 | Increasing Colorectal Cancer (CRC) Screening Among Hispanic Primary Care Patients | ||
| NCT00022711 | Temozolomide in Treating Patients With Relapsed or Progressive Small Cell Lung Cancer | ||
| NCT02143115 | Comparative Effectiveness of CTC & OC | ||
| NCT01380145 | MAGE-A3 Protein + AS15 as Consolidation for Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation | ||
| NCT05454280 | Post-Discharge Risk-Based Management in Patients Undergoing High-Risk Elective Major Cancer Operations (PRS II) | ||
| NCT03114527 | Phase II Trial of Ribociclib and Everolimus in Advanced Dedifferentiated Liposarcoma (DDL) and Leiomyosarcoma (LMS) | ||
| NCT03125928 | Clinical Trial of Atezolizumab With Paclitaxel, Trastuzumab, and Pertuzumab in Patients With Metastatic HER-2 Positive Breast Cancer | ||
| NCT00003264 | Cisplatin Plus Gemcitabine in Treating Patients With Advanced Squamous Cell Head and Neck Cancer | ||
| NCT00005021 | Combination Chemotherapy With or Without Biological Therapy in Treating Patients With Refractory Solid Tumor or Lymphoma | ||
| NCT00940277 | Couple-Focused Intervention for Breast Cancer Patients | ||
| NCT05498792 | Study of CBL0137 in Combination With Ipilimumab and Nivolumab Therapy in Melanoma | ||
| NCT02721147 | Pilot Study of an Intimacy Enhancement Intervention for Couples Facing Breast Cancer | ||
| NCT04441749 | nCLE For Diagnosis Of Peripheral Lung Nodules By Robotic Navigational Bronchoscopy | ||
| NCT03286062 | VM110 in Detection of Microscopic Tumors: A Phase I Study | ||
| NCT00005848 | R115777 in Treating Patients With Progressive, Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy | ||
| NCT01982591 | Heavy Metal Exposure in Predicting Peripheral Neuropathy in Patients With Stage I-III Breast Cancer Undergoing Chemotherapy | ||
| NCT00021372 | Paclitaxel and Estramustine in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma | ||
| NCT00021307 | Temozolomide Plus Carboplatin in Treating Patients With Recurrent Glioblastoma Multiforme | ||
| NCT00005037 | Temozolomide in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-small Cell Lung Cancer | ||
| NCT01962948 | Paclitaxel and Ganetespib in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer | ||
| NCT05274048 | Neratinib and Fam-Trastuzumab Deruxtecan in Advanced Gastro-esophageal Cancer Patients | ||
| NCT03179943 | Atezolizumab + Guadecitabine in Patients With Checkpoint Inhibitor Refractory or Resistant Urothelial Carcinoma | ||
| NCT03786692 | Phase II Randomized Trial of Carboplatin+Pemetrexed+Bevacizumab+/- Atezolizumab in Stage IV NSCLC | ||
| NCT02963610 | Phase I/II Study of Lenalidomide Plus Pembrolizumab in Patients With Solid Tumors With Expansion in Non-small Cell Lung Cancer | ||
| NCT02442323 | A Pilot Study of a Home-Based Walking Intervention for Pancreatic Cancer Patients | ||
| NCT02847429 | Randomized Trial of Crenolanib in Subjects With D842V Mutated GIST | ||
| NCT00586937 | Quality of Life in Lung Cancer Survivors | ||
| NCT06218628 | Pacritinib w/ Talazoparib in Pts w/ Myeloproliferative Neoplasms Unresponsive to JAK2 Inhibition | ||
| NCT00553800 | Study of Bevacizumab and Erlotinib in Patients With Advanced Non-small Cell Lung Cancer | ||
| NCT02211430 | Smoking Cessation for Low-Income Pregnant Women | ||
| NCT00003957 | Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Non-Hodgkin's Lymphoma | ||
| NCT03527108 | Nivolumab Plus Ramucirumab in Patients With Recurrent, Advanced, Metastatic NSCLC |
